Biggest News Aggregation in the World
📰 First Wave News

Page 14 - First Wave News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from First Wave. Real-time updates on events, politics, business and more.

'Transformative Event' For First Wave BioPharma: License Agreement for Hopeful Gastrointestinal Candidate From Sanofi - First Wave BioPharma (NASDAQ:FWBI), Sanofi (NASDAQ:SNY)

First Wave BioPharma Inc (NASDAQ: FWBI) announced an agreement with Sanofi SA (NASDAQ: SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, which First Wave will repurpose and develop for
Biopharma Inc James Sapirstein First Wave Biopharma First Wave

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

First Wave BioPharma's (NASDAQ: FWBI) Exclusive License: Repurposing Capeserod for GIT Disorder Solutions

First Wave BioPharma (NASDAQ: FWBI) experienced an impressive pre-market surge of approximately 85% on Thursday following the announcement of a licensing agreement with Sanofi (NASDAQ: SNY) concerning Capeserod, a potential treatment for gastrointestinal tract (GIT) disorders. The Agreement: According to the terms of the agreement, the biotech company based in Boca Raton, Florida, will obtain
United States Boca Raton Drug Administration First Wave Biopharma Right Now First Wave

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science